Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01358552|
Recruitment Status : Terminated (Insufficient number of participants)
First Posted : May 23, 2011
Last Update Posted : May 1, 2013
|Condition or disease||Intervention/treatment|
|Pregnancy||Other: Néevo®/ NéevoDHA®|
|Study Type :||Observational|
|Actual Enrollment :||53 participants|
|Official Title:||Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||March 2012|
|Actual Study Completion Date :||March 2012|
Subjects who have been prescribed Néevo/NéevoDHA® daily.
Other: Néevo®/ NéevoDHA®
Néevo®/NéevoDHA® is an orally administered medical food indicated for the dietary management of impaired metabolic processes in women under a doctor's care who face high to intermediate risk pregnancies and are unable to fully metabolize or absorb folic acid. Néevo®/ NéevoDHA® contains L-methylfolate, the biologically active and immediately bioavailable form of folate.
- To determine the safety and tolerability of Néevo®/NéevoDHA® as measured by side effects and compliance [ Time Frame: Week 4 ]To collect data from patient surveys on the patient utilization and effectiveness of Néevo®/NéevoDHA® in a "real world" setting.
- To determine overall patient satisfaction with Néevo®/NéevoDHA® using a 9-point satisfaction scale [ Time Frame: Week 4 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01358552
|United States, Texas|
|Noe Lira, M.D.|
|Corpus Christi, Texas, United States, 78411|
|Principal Investigator:||Noe Lira, M.D.||Noe Lira, M.D.|